Device and Diagnostics Dealmaking Quarterly Statistics, Q4 2011
Medical device companies raised $800 million in the fourth quarter of 2011, and venture capital represented half of that amount. Just over $4 billion was spent to acquire medical device companies, down 50% from Q3’s $8 billion. In vitro diagnostics/research financings were well above the previous quarter, raking in a total of $269 million, with late-stage rounds again bringing in most of the Q4 money. Only five M&A deals were completed, totalling $915 million – way down from Q3’s $2.8 billion for the same number of deals.
You may also be interested in...
Deal worth up to $325 million makes Bard first in line to enter the U.S. market with a drug-coated balloon. Firm anticipates PMA submission for Moxy in 2014.
Imaging device maker Fujifilm buys SonoSite for $995 million, gaining handheld ultrasound devices including Edge, M-Turbo, MicroMaxx and NanoMaxx systems for applications including critical care, musculoskeletal, ob/gyn, vascular, cardiac and superficial imaging.
Although privately held Oceana’s two products – Solesta and Deflux – are regulated by FDA as Class III medical devices, Salix intends to market them with existing sales forces.